Stay updated with breaking news from Daniel Karlin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Work Productivity and Activity Impairment Associated with Generalized Anxiety Disorder among Adults in the United States Phong...
Jim Cramer recently hyped up one of his guests in advance of his CNBC show "Mad Money," posting on X that people "will be very interested in MindMed for certain ... LSD," and he made sure his interview did not disappoint. Mind Medicine Inc. (NASDAQ:MNMD) sees a massive market opportunity ahead, citing 21% of U.S. adults with an anxiety disorder, an estimated 4.4% of U.S. adults with attention-deficit/hyperactivity disorder (ADHD) and a $461 billion economic cost from autism spectrum disorder by
This March 2024 psychiatry month in review highlights positive phase 2b and phase 2a data for drugs targeting treatment-resistant depression, generalized anxiety disorder, and PTSD.
Studies show benefits for people with high anxiety, depression, and PTSD, but there are questions about how these drugs might be used.